Form 4: Cytokinetics Director Robert Harrington Sells 253 Shares at $54.61
SEC Form 4 Filing
Director Robert Arthur Harrington of Cytokinetics Inc. (CYTK) sold 253 shares of common stock at a price of $54.61 on July 5, 2024.
Summary
- On July 5, 2024, Robert Arthur Harrington, a director of Cytokinetics Inc. (CYTK), sold 253 shares of the company's common stock.
- The sale was executed at a price of $54.61 per share.
- Following the transaction, Harrington directly owns 15,516 shares of Cytokinetics Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment of interests.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's overall holdings.
Key Dates
| Date | Description |
|---|---|
| 07/05/2024 | Date of the stock sale transaction. |
| 07/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.